Abstract
The pharmacokinetic and pharmacodynamic effects of concomitant administration of alprazolam and fluoxetine were studied in this double-blind parallel study in 80 healthy, male volunteers. Subjects were randomly assigned to one of four treatment groups. Drug treatments consisted of 4-day regimens of 1 mg alprazolam four times daily, 60 mg fluoxetine every morning, 1 mg alprazolam four times daily and 60 mg fluoxetine every morning, and placebo four times daily. Psychomotor performance, mood status, and degree of sedation were evaluated at designated times. Combined administration of alprazolam and fluoxetine resulted in an approximate 30% increase in plasma alprazolam concentrations relative to plasma concentrations following the administration of alprazolam alone. There were no significant differences in fluoxetine or norfluoxetine plasma concentrations between the alprazolam/fluoxetine and fluoxetine treatments. Psychomotor decrements increased when fluoxetine was administered with alprazolam relative to alprazolam administration alone. Psychomotor performance of the fluoxetine treatment group was not significantly different from that of the placebo group. No significant changes were observed in mood status, and sedation was minimal in all treatment groups. As when any two psychoactive drugs are administered together, increased patient monitoring and patient education is recommended when alprazolam and fluoxetine are prescribed concurrently.
Similar content being viewed by others
References
Adams W, Bombardt P, Brewer J (1984) Normal-phase liquid chromatographic determination of alprazolam in human serum. Anal Chem 56:1594–1600
Fuller R, Rathbun R, Parli C (1976) Inhibition of drug metabolism by fluoxetine. Res Commun Chem Pathol Pharmacol 13:353–356
Gibaldi M, Perrier O (1987) Pharmacokinetics, 2nd edn. Dekker, New York
Lemberger L, Rowe H, Carmichael R, Oldham S, Horng J, Bymaster F, Wong D (1978a) Pharmacologic effects in man of a specific serotonin reuptake inhibitor. Science 199:436–437
Lemberger L, Rowe H, Carmichael R, Crabtree R, Horng J, Bymaster F, Wong D (1978b) Fluoxetine, a selective serotonin up/take inhibitor. Clin Pharmacol Ther 23:421–429
Lemberger L, Bergstrom R, Wolen R, Farid N, Enas G, Aronoff G (1985) Fluoxetine: Clinical pharmacology and physiologic disposition. J Clin Psychiatry 46[3 sec 2]:14–19
Lemburger L, Rowe H, Bosomworth J, Tenbarge J, Bergstrom R (1988) The effect of fluoxetine on the pharmacokinetics and psychomotor responses of diazepam. Clin Pharmacol Ther 43:412–419
McNair D, Lorr M, Droppleman L (1971) EITS Manual for Profile of Mood States, San Diego, Educational and Industrial Testing Service
Moskowitz H, Burns M (1988) The effects on performance of two antidepressants, alone and in combination with diazepam. Prog Neuropsychopharmacol Biol Psychiatry 12:783–792
Nash J, Bopp R, Carmichael R, Farid K, Lemberger L (1982) Determination of fluoxetine and norfluoxetine in plasma by gas chromatography with electron-capture detection. Clin Chem 28[10]:2100–2102
SAS Institute Inc, (1985) SAS User's Guide: Statistics, Version 5 edn. Cary, North Carolina
Smith, R, Kroboth P (1987) Influence of dosing regimen on alprazolam and metabolite serum concentrations and tolerance to sedative and psychomotor effects. Psychopharmacology 93:105–112
Smith R, Gwilt P, Wright E (1983) Single and multiple dose pharmacokinetics of oral alprazolam in healthy smoking and nonsmoking men. Clin Pharmacol 2:139–143
Smith R, Kroboth P, VanderLugt J, Phillips J, Juhl R (1984) Pharmacokinetics and pharmacodynamics of alprazolam after oral and IV administration. Psychopharmacology 84:452–456
Sommi R, Crismon M, Bowden C (1987) Fluoxetine: A serotonin-specific, second-generation antidepressant. Pharmacotherapy 7[1]:001–015
Spielberger C, Gorsuch R, Lushene R, Vagg P, Jacobs G (1983) Manual for the state-trait anxiety inventory (Form Y). Palo Alto Consulting Psychologists Press
Wechsler D (1955) A manual for the Wechsler Adult Intelligence Scale. Psychological Corporation, New York
Wernicke J (1985) The side effect profile and safety of fluoxetine. J Clin Psychiatry 46[3 sec 2]:59–67
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lasher, T.A., Fleishaker, J.C., Steenwyk, R.C. et al. Pharmacokinetic pharmacodynamic evaluation of the combined administration of alprazolam and fluoxetine. Psychopharmacology 104, 323–327 (1991). https://doi.org/10.1007/BF02246031
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02246031